195 related articles for article (PubMed ID: 24391883)
1. CHRNA7 polymorphisms and response to cholinesterase inhibitors in Alzheimer's disease.
Weng PH; Chen JH; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM; Chen YC
PLoS One; 2013; 8(12):e84059. PubMed ID: 24391883
[TBL] [Abstract][Full Text] [Related]
2. Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.
Russo P; Kisialiou A; Moroni R; Prinzi G; Fini M
Curr Drug Targets; 2017; 18(10):1179-1190. PubMed ID: 26424395
[TBL] [Abstract][Full Text] [Related]
3. Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.
Braga IL; Silva PN; Furuya TK; Santos LC; Pires BC; Mazzotti DR; Bertolucci PH; Cendoroglo MS; Smith MC
Am J Alzheimers Dis Other Demen; 2015 Mar; 30(2):139-44. PubMed ID: 24951635
[TBL] [Abstract][Full Text] [Related]
4. CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients.
Clarelli F; Mascia E; Santangelo R; Mazzeo S; Giacalone G; Galimberti D; Fusco F; Zuffi M; Fenoglio C; Franceschi M; Scarpini E; Forloni G; Magnani G; Comi G; Albani D; Martinelli Boneschi F
J Alzheimers Dis; 2016 Apr; 52(4):1203-8. PubMed ID: 27104904
[TBL] [Abstract][Full Text] [Related]
5. CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking.
Weng PH; Chen JH; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM; Chen YC
Sci Rep; 2016 Jun; 6():27231. PubMed ID: 27249957
[TBL] [Abstract][Full Text] [Related]
6. Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease.
Scacchi R; Gambina G; Broggio E; Corbo RM
Int J Geriatr Psychiatry; 2014 Jun; 29(6):610-5. PubMed ID: 24150894
[TBL] [Abstract][Full Text] [Related]
7. BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
Chianella C; Gragnaniello D; Maisano Delser P; Visentini MF; Sette E; Tola MR; Barbujani G; Fuselli S
Eur J Clin Pharmacol; 2011 Nov; 67(11):1147-57. PubMed ID: 21630031
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
[TBL] [Abstract][Full Text] [Related]
9. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study.
Miranda LF; Gomes KB; Silveira JN; Pianetti GA; Byrro RM; Peles PR; Pereira FH; Santos TR; Assini AG; Ribeiro VV; Tito PA; Matoso RO; Lima TO; Moraes EN; Caramelli P
J Alzheimers Dis; 2015; 45(2):609-20. PubMed ID: 25589728
[TBL] [Abstract][Full Text] [Related]
11. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P
Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879
[TBL] [Abstract][Full Text] [Related]
13. Effect of genetic polymorphisms on Alzheimer's disease treatment outcomes: an update.
Sumirtanurdin R; Thalib AY; Cantona K; Abdulah R
Clin Interv Aging; 2019; 14():631-642. PubMed ID: 30992661
[TBL] [Abstract][Full Text] [Related]
14. Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort.
Wattmo C; Wallin AK; Minthon L
BMC Neurol; 2012 Nov; 12():134. PubMed ID: 23126532
[TBL] [Abstract][Full Text] [Related]
15. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
Wattmo C; Minthon L; Wallin ÅK
Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.
Kröger E; van Marum R; Souverein P; Egberts T
Drugs Aging; 2010 Aug; 27(8):663-75. PubMed ID: 20658794
[TBL] [Abstract][Full Text] [Related]
17. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease.
Droogsma E; van Asselt D; Diekhuis M; Veeger N; van der Hooft C; De Deyn PP
Int Psychogeriatr; 2015 Aug; 27(8):1323-33. PubMed ID: 25779465
[TBL] [Abstract][Full Text] [Related]
18. Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment.
Pyun JM; Ryoo N; Park YH; Kim S
Alzheimers Res Ther; 2021 Jan; 13(1):10. PubMed ID: 33402198
[TBL] [Abstract][Full Text] [Related]
19. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
Haywood WM; Mukaetova-Ladinska EB
Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement.
Wattmo C; Londos E; Minthon L
Curr Alzheimer Res; 2018; 15(10):905-916. PubMed ID: 29732972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
